rs121908258
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_130468.4(CHST14):c.878A>G(p.Tyr293Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_130468.4 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndrome, musculocontractural type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Ehlers-Danlos syndrome, musculocontractural typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251456 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727240 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74468 show subpopulations
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, musculocontractural type Pathogenic:1Other:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 293 of the CHST14 protein (p.Tyr293Cys). This variant is present in population databases (rs121908258, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of autosomal recessive CHST14-related conditions (PMID: 10766984, 20004762, 20533528, 21744491). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2339). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CHST14 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CHST14 function (PMID: 20004762). For these reasons, this variant has been classified as Pathogenic. -
- -
Ehlers-Danlos syndrome, musculocontractural type 1 Pathogenic:1
- -
not provided Pathogenic:1
The Y293C likely pathogenic variant in the CHST14 gene has been reported in the homozygous state in a patient with adducted thumb-clubfoot syndrome (Dundar et al., 2009). This variant has also been reported a patient with dermatan 4-O-sulfotransferase 1 deficiency who also harbored an additional CHST14 variant in trans (Shimizu et al., 2011). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The Y293C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Finally, functional studies demonstrate that this variant leads to decreased sulfotransferase activity (Miyake et al., 2010). -
Cardiovascular phenotype Pathogenic:1
The p.Y293C pathogenic mutation (also known as c.878A>G), located in coding exon 1 of the CHST14 gene, results from an A to G substitution at nucleotide position 878. The tyrosine at codon 293 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant has been identified as homozygous or compound heterozygous in multiple individuals with dermatan 4-O-sulfotransferase 1 deficient Ehlers-Danlos Syndrome (D4ST1-deficient EDS) (Dündar M et al. Am. J. Hum. Genet., 2009 Dec;85:873-82; Miyake N et al. Hum. Mutat., 2010 Aug;31:966-74; Shimizu K et al. Am. J. Med. Genet. A, 2011 Aug;155A:1949-58). A functional study shows that this variant causes reduced sulfotransferase activity in transfected cells (Miyake N et al. Hum. Mutat., 2010 Aug;31:966-74). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at